Anna Gardin: Incredible Initiative to Measure Clinician’s Own Lp(a) On The Spot at ESOC 2026
Anna Gardin, Neurology Resident at Stroke Unit, “G. Martino” University Hospital, shared on LinkedIn:
”At ESOC 2026, an incredible initiative gave clinicians the chance to measure their own Lp(a) on the spot.
As healthcare professionals, we talk to our patients about cardiovascular risk every day, but how often do we actually look at our own?
Fortunately, my Lp(a) are low (<15 nmol/L).
But this kind of screening is a powerful reminder: elevated Lp(a) can be the nudge we need to double down on the modifiable factors we can control.
And for those with high levels?
The good news is that the therapeutic landscape is evolving.
Novel Lp(a)-lowering agents are on the horizon, and the science is moving fast.
Lead by example. Know your risk.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 17:36Paul Whiteley: Neurodevelopmental and Autism Risks in Fetal and Neonatal Alloimmune Thrombocytopenia
-
Jun 24, 2026, 17:22Kavitha Dev: A Low Platelet Count Isn’t Always Critical, But It Should Never Be Ignored
-
Jun 24, 2026, 17:04Recurrent Cervical Internal Carotid Vasospasm Linked to Autosomal Recessive PTGIS Defect – International Journal of Stroke
-
Jun 24, 2026, 16:49Gaurav Kharya: Bridging the Gap in Safe Blood Access for Patients Who Can’t Wait
-
Jun 24, 2026, 16:40William Wallace: Vitamin C and Collagen Work as One Biological System
-
Jun 24, 2026, 16:32Arlindo Nascimento de Lemos Junior: Thrombus Echogenicity as a Predictor of Post-Thrombotic Syndrome Severity After DVT
-
Jun 24, 2026, 16:09Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
-
Jun 24, 2026, 16:03Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
-
Jun 24, 2026, 15:57Maia Meier: Women with Bleeding Disorders Reach the Summit of Mont Blanc